Barclays Upgrades Align Technology to Overweight, Maintains Price Target to $200
3/17/2026
Impact: 70
Healthcare
Barclays analyst Glen Santangelo has upgraded Align Technology (NASDAQ: ALGN) from Equal-Weight to Overweight. The price target for the stock remains unchanged at $200.
AI summary, not financial advice
Share: